Pharmaceutical Grade Dimethylformamide from Japan
Pharma-grade DMF meets USP/EP standards for use in drug synthesis and peptide manufacturing, ensuring low impurity levels. It is specifically dimethylformamide, an acyclic amide, directly under HTS 2924.19.11.20.
Duty Rate — Japan → United States
23.8%
Rate breakdown
9903.04.6211.3%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include FDA Drug Master File references and CoA; segregate from general chemicals to prevent contamination claims
• Common pitfall: missing DMF-specific hazard declarations